Drug Information

Drug General Information
Drug ID
D0V3RE
Former ID
DNC013850
Drug Name
BTNP
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529791]
Formula
C16H13BrO2
Canonical SMILES
C1CC(=CBr)OC(=O)C1C2=CC=CC3=CC=CC=C32
InChI
1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-12)14-7-3-5-11-4-1-2-6-13(11)14/h1-7,10,15H,8-9H2/b12-10+
InChIKey
BYUCSFWXCMTYOI-ZRDIBKRKSA-N
PubChem Compound ID
5940264
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529791]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529791J Med Chem. 2008 Dec 11;51(23):7327-43.Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.
Ref 529791J Med Chem. 2008 Dec 11;51(23):7327-43.Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.